ampelopsin has been researched along with Cognitive Decline in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (42.86) | 24.3611 |
2020's | 4 (57.14) | 2.80 |
Authors | Studies |
---|---|
He, X; Li, Y; Liu, D; Liu, T; Lv, W; Wang, Y | 1 |
Chen, JG; Chen, LL; Li, JE; Sun, CC; Wang, WJ; Yin, ZP; Zhang, QF; Zheng, GD | 1 |
Davies, DL; Liang, J; Omran, AA; Shao, AS; Shao, XM; Watanabe, J; Watanabe, S; Xue, C; Zhang, J; Zhang, Z | 1 |
Feng, S; He, J; Li, Q; Ling, H; Song, Z; Wang, Z; Yan, C; Yang, S | 1 |
Feng, S; He, J; Liao, D; Ling, H; Wu, D; Yang, J; Yang, S; Zhu, Z | 1 |
Feng, SD; He, JQ; Ling, HY; Yang, JH; Yang, SS; Zhang, KF; Zhu, ZM | 1 |
Cheng, C; Feng, ZJ; Jiang, H; Liu, CM; Ma, JQ; Sun, JM; Yang, HX; Yang, W | 1 |
7 other study(ies) available for ampelopsin and Cognitive Decline
Article | Year |
---|---|
Ampelopsin Improves Cognitive Impairment in Alzheimer's Disease and Effects of Inflammatory Cytokines and Oxidative Stress in the Hippocampus.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Alzheimer Disease; Animals; Cognitive Dysfunction; Cytokines; Dinoprost; Disease Models, Animal; Flavonoids; Hippocampus; Inflammation; Male; Maze Learning; Memory, Short-Term; Neuroprotective Agents; Oxidative Stress; Rats | 2020 |
Dihydromyricetin Improves Cognitive Impairments in d-Galactose-Induced Aging Mice through Regulating Oxidative Stress and Inhibition of Acetylcholinesterase.
Topics: Acetylcholinesterase; Aging; Animals; Cognitive Dysfunction; Flavonols; Galactose; Mice; Neurodegenerative Diseases; Oxidative Stress | 2022 |
Dihydromyricetin improves social isolation-induced cognitive impairments and astrocytic changes in mice.
Topics: Animals; Astrocytes; Cognitive Dysfunction; Flavonols; Hippocampus; Mice; Social Isolation | 2022 |
Dihydromyricetin alleviates hippocampal ferroptosis in type 2 diabetic cognitive impairment rats via inhibiting the JNK-inflammatory factor pathway.
Topics: Animals; Cognitive Dysfunction; Diabetes Mellitus, Type 2; Ferroptosis; Hippocampus; Iron; Rats | 2023 |
Dihydromyricetin improves type 2 diabetes-induced cognitive impairment via suppressing oxidative stress and enhancing brain-derived neurotrophic factor-mediated neuroprotection in mice.
Topics: Ampelopsis; Animals; Blood Glucose; Brain-Derived Neurotrophic Factor; Cognitive Dysfunction; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Flavonols; Maze Learning; Mice; Neuroprotection; Neuroprotective Agents; Oxidative Stress; Phytotherapy; Plant Extracts | 2018 |
[The effects of dihydromyricetin on cognitive dysfunction in type 2 diabetes mice].
Topics: Animals; Blood Glucose; Brain-Derived Neurotrophic Factor; Cognitive Dysfunction; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Flavonols; Hippocampus; Learning; Memory; Mice; Mice, Inbred C57BL | 2017 |
Dihydromyricetin Inhibits Lead-Induced Cognitive Impairments and Inflammation by the Adenosine 5'-Monophosphate-Activated Protein Kinase Pathway in Mice.
Topics: AMP-Activated Protein Kinase Kinases; Ampelopsis; Animals; Apoptosis; Brain; Cognitive Dysfunction; Cytokines; Flavonols; Humans; Inflammation; Lead; Mice; NF-kappa B; Phosphorylation; Plant Extracts; Protein Kinases; Toll-Like Receptor 4 | 2018 |